# ClinicalTrials.gov record NCT00171613

> PeptideScanner retained ClinicalTrials.gov record NCT00171613 at 2026-07-30T22:14:20.909Z. Its registry update date was 2012-04-30, and PeptideScanner's reviewed identity mapping was octreotide.

- Evidence object: `story:clinicaltrials-gov-nct00171613-octreotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2012-04-30
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00171613-octreotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00171613-octreotide-v1.json
- Content SHA-256: `667a8084bd29a55b1f7616521c1bb847eababad4a3ece09c0d9bd764acafc9dd`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT00171613 ([`ctg-observation-nct00171613-2012-04-30-55b775ca5b74`](#source-ctg-observation-nct00171613-2012-04-30-55b775ca5b74))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00171613 at 2026-07-30T22:14:20.909Z. Its registry update date was 2012-04-30, and PeptideScanner's reviewed identity mapping was octreotide. ([`ctg-observation-nct00171613-2012-04-30-55b775ca5b74`](#source-ctg-observation-nct00171613-2012-04-30-55b775ca5b74))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00171613 at 2026-07-30T22:14:20.909Z. Its registry update date was 2012-04-30, and PeptideScanner's reviewed identity mapping was octreotide. ([`ctg-observation-nct00171613-2012-04-30-55b775ca5b74`](#source-ctg-observation-nct00171613-2012-04-30-55b775ca5b74))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00171613-2012-04-30-55b775ca5b74`](#source-ctg-observation-nct00171613-2012-04-30-55b775ca5b74))

## Sources

<a id="source-ctg-observation-nct00171613-2012-04-30-55b775ca5b74"></a>
- **ClinicalTrials.gov record NCT00171613 · retained source version 2012-04-30:55b775ca5b74ec7dbd2dd92543ec65d11d3cda85728dff7cff49c985dedffa08** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00171613) (`ctg-observation-nct00171613-2012-04-30-55b775ca5b74`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00171613." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00171613-octreotide-v1.json SHA-256: 667a8084bd29a55b1f7616521c1bb847eababad4a3ece09c0d9bd764acafc9dd.